DSP Mutual Fund
Up to one year: absolute. Longer: annualised. Category = median of Index Funds direct-plan Growth funds.
| Period | This fund | Category median | Rank in category |
|---|---|---|---|
| 1 month | -3.47% | -5.37% | — |
| 3 months | +0.43% | -4.10% | — |
| 6 months | +14.71% | +3.59% | — |
| 1 year | +12.67% | +1.93% | #13 of 318 Top 5% |
| 3 years | — | +7.42% | — |
| 5 years | — | +6.41% | — |
| 10 years | — | +10.93% | — |
| Since launch of NAV data | +11.18% | — | — |
| Window | High | Low |
|---|---|---|
| 1 month | 12.0075 | 11.4562 |
| 3 months | 12.0613 | 11.4070 |
| 6 months | 12.0613 | 9.9009 |
| 1 year | 12.0613 | 9.7887 |
A period is a dash when the fund has not existed that long or its NAV history has a hole at the start date — never a partial figure.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | YTD | |
|---|---|---|---|---|---|---|---|
| This fund | — | — | — | — | — | — | +10.26% |
| Category median | +15.51% | +25.21% | +3.61% | +21.04% | +9.93% | +7.90% | -2.53% |
Twenty checks of five points each: performance, portfolio, operations, and risk against reward. Only checks we have data for are counted.
Risk-free rate 6.06% (3-year annualised return of the NSE 1-day (overnight) rate index). This category has no reference index in our data, so benchmark-relative ratios are not shown.
| Ratio | This fund | Category median | Against category |
|---|---|---|---|
| Sharpe ratio | — | 0.46 | — |
| Sortino ratio | — | 0.65 | — |
| Standard deviation | — | 13.27% | — |
| Maximum drawdown | — | -15.52% | — |
| Beta | — | 1.00 | — |
| R-squared | — | 100.0% | — |
| Jensen's alpha | — | -0.41% | — |
| Treynor ratio | — | 2.09 | — |
| Information ratio | — | -3.62 | — |
| Upside capture | — | 99.6% | — |
| Downside capture | — | 100.0% | — |
Computed from this fund's actual NAVs. A SIP buys at the first NAV of each month and is valued at the latest NAV. Past returns do not guarantee future ones.
Weights are % of the scheme's assets from the latest month-end disclosure available to Tradinity. The feed carries weights only: no quantities or rupee values.
Valuation ratios are weighted over the holdings we can match to a company (harmonic mean for P/E) and are withheld when they cover under half the portfolio.
| Holding | Sector | Weight | 3M change | P/E |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | 18.08% | — | 146.5 |
| Divi's Laboratories Limited | Healthcare | 10.35% | — | 83.9 |
| Apollo Hospitals Enterprise Limited | Healthcare | 7.88% | — | 74.7 |
| Cipla Limited | Healthcare | 6.82% | — | 35.4 |
| Max Healthcare Institute Limited | Healthcare | 6.67% | — | 126.0 |
| Laurus Labs Limited | Healthcare | 6.41% | — | 122.5 |
| Torrent Pharmaceuticals Limited | Healthcare | 6.39% | — | 78.2 |
| Dr. Reddy's Laboratories Limited | Healthcare | 6.05% | — | 154.7 |
| Lupin Limited | Healthcare | 4.57% | — | 13.3 |
| Aurobindo Pharma Limited | Healthcare | 4.09% | — | 37.4 |
| Fortis Healthcare Limited | Healthcare | 4.07% | — | 257.5 |
| Glenmark Pharmaceuticals Limited | Healthcare | 3.21% | — | 321.6 |
| Alkem Laboratories Limited | Healthcare | 2.68% | — | 28.9 |
| Biocon Limited | Healthcare | 2.53% | — | 597.3 |
| Zydus Lifesciences Limited | Healthcare | 2.50% | — | 33.3 |
| IPCA Laboratories Limited | Healthcare | 2.36% | — | 39.3 |
| Mankind Pharma Limited | Healthcare | 2.36% | — | 47.4 |
| Abbott India Limited | Healthcare | 1.15% | — | 35.7 |
| Piramal Pharma Limited | Healthcare | 1.15% | — | 39.2 |
| Syngene International Limited | Healthcare | 0.66% | — | 64.2 |
| TREPS / Reverse Repo Investments | — | 0.15% | — | — |
This is a paid feature
Comparing more months of this fund's own portfolio history is available on paid plans.
Sign inExpense ratio by month: Oct 25 0.24% · Nov 25 0.24% · Dec 25 0.23% · Jan 26 0.25% · Feb 26 0.25% · Mar 26 0.30% · Apr 26 0.50% · May 26 0.32% · Jun 26 0.39% · Jul 26 0.37% · Aug 26 0.41% · Sep 26 0.40%
Nil
The investment objective of the Scheme is to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error.; There is no assurance that the investment objective of the Scheme will be achieved.
Fund house: website · factsheets · monthly portfolio · annual report
Not available: Morningstar rating (proprietary). "NAV history from" is the first NAV we hold.
Returns are computed by Tradinity from each scheme's own published NAV, so they are net of the fund's expenses. Periods over one year are annualised (CAGR). Past performance does not indicate future returns. Only Growth-option schemes are ranked: an IDCW scheme pays cash out of its NAV, so its NAV understates what an investor earned.
